glp 1 agonist and heart failure GLP-1 receptor agonist-based therapies cardiovascular risk: a review of mechanisms Effects of GLP-1 Receptor Agonists
Description
Diabetes Care 41 , 620622 (2018)
However, phosphorylated GSK-3 was significantly upregulated on day 21 in the Liraglutide group, suggesting enhanced Wnt-signaling repressing adipogenesis [20]
2 Classification of currently available glucagon-like peptide-1 receptor agonists (GLP-1 RAs) by structure and duration of action
Rev Diabetic Stud
